Relationship Between Effect of 60Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level
|Updated:2026-03-12
|
Relationship Between Effect of 60Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level
Relationship Between Effect of 60Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level
解放军医学杂志(英文版)1988年第2期 页码:197-200
Affiliations:
1. Department of Pathology Fourth Military Medical University
2. ,Xi’an
3. Department of Radiotherapy
4. Xijing Hospital
Author bio:
Funds:
DOI:
中图分类号:
纸质出版:1988
Accepted:
Scan QR Code
Relationship Between Effect of 60Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level[J]. 解放军医学杂志(英文版), 1988,(2):197-200.
[1]隋延仿,潘仁沽.Relationship Between Effect of ~(60)Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level[J].Journal of Medical Colleges of PLA,1988(02):197-200.
Relationship Between Effect of 60Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level[J]. 解放军医学杂志(英文版), 1988,(2):197-200.DOI:
[1]隋延仿,潘仁沽.Relationship Between Effect of ~(60)Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level[J].Journal of Medical Colleges of PLA,1988(02):197-200.DOI:
Relationship Between Effect of 60Co Radiotherapy on Nasopharyngeal Carcinoma and EB Virus Capsid Antigen-lmmunoglobulin A Antibody Level
摘要
Abstract
<
正
>
By using immunofluorescent cytochemical method
EB-VCA-IgA antibody levelswere studied in 35 cases of nasopharyngeal carcinoma.It was found that VCA-IgAantibody level declined with the improvement of the patient’s condition and rose up withthe worsening of the disease in most cases.It is indicated that the change of EB-VCA-IgAantibody level might be used as an objective indication for the determination of
60
Coradiotherapy effect.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.